Celgene Corporation on Monday announced the selection of PhageNova Bio, Inc. as the first client in the Thomas O. Daniel Research Incubator and Collaboration Center, which offers state-of-the-art lab space, resources and support for promising scientists and companies to accelerate medical discoveries and innovations. PhageNova Bio, Inc. is an early stage biotechnology company developing a unique approach to systemically administered targeted gene delivery. Read more here.